Walter Bertin

Dr. Walter Bertin

Federsalus
+2

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2021 in Cosmetics
Verified
Journal Article
Open access
PDF file
IRIrene Ragusa
Irene Ragusa
GNGiulia Nerina Nardone
Giulia Nerina Nardone
SZSamuele Zanatta
Samuele Zanatta
WBWalter Bertin
Walter Bertin
Emanuele AmadioEmanuele Amadio
Emanuele Amadio
Spirulina stands out as a sustainable bioactive microalga with health-promoting properties, and an important active ingredient of natural cosmetics products. Currently, Spirulina has been incorporated in topical skin-care formulations, such as a moisturizing, antiwrinkles, antiaging and antiacne agent. Furthermore, this microalga is used by cosmetic formulators to promote healthy sunscreen protection, to treat skin pigmentation disorders and to heal wounds. Most of commercial cosmetics claim a large range of Spirulina properties, including antioxidant, revitalizing, remineralizing, moisturizing, protecting alongside cleansing and shining action, both for hair and for skin. In this review, recent cosmetic applications of Spirulina are revised, by highlighting its ability in improving skin appearance and health. Additionally, the analysis of the Spirulina cosmetic benchmark is discussed. Looking at the current emergence of the beauty industry, many Spirulina extracts and dry powder/flakes, both the starting ingredient and final Spirulina-based cosmetic products, are available on the market. In this industrial field, Spirulina—mainly Spirulina platensis and Spirulina maxima—is used either as a powder, like in the case of cheaper products, or as a phycocyanin-rich blue extract, particularly in the luxury market. It is likely that, in the coming years, diversity, quality and topical applications of Spirulina will rapidly increase.

Verified
Journal Article
Open access
PDF file
Tiziana M.G. PecoraTiziana M.G. Pecora
Tiziana M.G. Pecora
BRBarbara Ragazzo
Barbara Ragazzo
WBWalter Bertin
Walter Bertin
ARAlessia Ragonese
Alessia Ragonese
MMMarco Mascagni
Marco Mascagni
Rosario PignatelloRosario Pignatello
Rosario Pignatello
Background: The study aimed at assessing the mucoadhesive properties and the barrier effect of a formulation, labelled as AL2106, containing sodium chondroitin sulfate (ChS), xyloglucan from tamarind seed extract, and glycerol, by evaluating the capacity to adhere to a layer of mucin, the rheological synergism and the barrier effect in comparison to the marketed Esoxx One medical device. AL2106 is a medical device distributed by Alfasigma SpA, Italy with REF FTP57 (Manufacturer: Labomar SpA); it is analogous to Esoxx One medical device: the two products are drinkable solutions that, after swallowing, adhere to the esophageal mucosa, protecting it from the corrosive effect of the gastric acid reflux. AL2106 has been conceived to be better performing in terms of duration of the barrier effect compared to Esoxx One. Methods: The mucoadhesive properties, rheological behavior, buffering capacity against acidity, and film-forming ability with the resultant protecting effect on esophagus mucosa (caffeine permeation test) was compared between the two products. Results: The mucoadhesivity of the formulations was shown in vitro: both remained adherent to a mucin layer, also when the support was rotated by 90°, and when the film layer was washed with water, intended to simulate the washout due to swallowing. AL2106 showed a good buffering efficacy, being able to absorb at least 50% of its weight of 0.03 M HCl while maintaining the pH above 4. The film-forming effect and barrier properties of AL2106 and Esoxx One were confirmed by an in vitro study on reconstructed human esophageal epithelium. A greater film-forming efficacy of AL2106, lasting for at least 5 h, than Esoxx One was observed. Noteworthy, the barrier function of esophageal tissues was shown to be preserved after the application of both formulations. Conclusions: The combination of ChS with the mucoadhesive glycerol−xyloglucan complex and other excipients, which contribute to the barrier effect and to mucoadhesion, contained in AL2106, allowed a longer-lasting protective effect than Esoxx One, proving its effectivity and safety for oral use.